Karpanen T - Search Results

1

T-cell receptor gene therapy--ready to go viral?

Karpanen T, Olweus J. Karpanen T, et al. Mol Oncol. 2015 Dec;9(10):2019-42. doi: 10.1016/j.molonc.2015.10.006. Epub 2015 Oct 20. Mol Oncol. 2015. PMID: 26548533 Free PMC article. Review.

2

The Potential of Donor T-Cell Repertoires in Neoantigen-Targeted Cancer Immunotherapy.

Karpanen T, Olweus J. Karpanen T, et al. Front Immunol. 2017 Dec 11;8:1718. doi: 10.3389/fimmu.2017.01718. eCollection 2017. Front Immunol. 2017. PMID: 29321773 Free PMC article. Review.

3

Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin.

Enholm B, Karpanen T, Jeltsch M, Kubo H, Stenback F, Prevo R, Jackson DG, Yla-Herttuala S, Alitalo K. Enholm B, et al. Among authors: karpanen t. Circ Res. 2001 Mar 30;88(6):623-9. doi: 10.1161/01.res.88.6.623. Circ Res. 2001. PMID: 11282897

4

Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1.

Jha SK, Rauniyar K, Karpanen T, Leppänen VM, Brouillard P, Vikkula M, Alitalo K, Jeltsch M. Jha SK, et al. Among authors: karpanen t. Sci Rep. 2017 Jul 7;7(1):4916. doi: 10.1038/s41598-017-04982-1. Sci Rep. 2017. PMID: 28687807 Free PMC article.

5

An Evolutionarily Conserved Role for Polydom/Svep1 During Lymphatic Vessel Formation.

Karpanen T, Padberg Y, van de Pavert SA, Dierkes C, Morooka N, Peterson-Maduro J, van de Hoek G, Adrian M, Mochizuki N, Sekiguchi K, Kiefer F, Schulte D, Schulte-Merker S. Karpanen T, et al. Circ Res. 2017 Apr 14;120(8):1263-1275. doi: 10.1161/CIRCRESAHA.116.308813. Epub 2017 Feb 8. Circ Res. 2017. PMID: 28179432 Free PMC article.

6

Role of lymphangiogenic factors in tumor metastasis.

He Y, Karpanen T, Alitalo K. He Y, et al. Among authors: karpanen t. Biochim Biophys Acta. 2004 Mar 4;1654(1):3-12. doi: 10.1016/j.bbcan.2003.07.003. Biochim Biophys Acta. 2004. PMID: 14984763 Review.

7

CCBE1 enhances lymphangiogenesis via A disintegrin and metalloprotease with thrombospondin motifs-3-mediated vascular endothelial growth factor-C activation.

Jeltsch M, Jha SK, Tvorogov D, Anisimov A, Leppänen VM, Holopainen T, Kivelä R, Ortega S, Kärpanen T, Alitalo K. Jeltsch M, et al. Among authors: karpanen t. Circulation. 2014 May 13;129(19):1962-71. doi: 10.1161/CIRCULATIONAHA.113.002779. Epub 2014 Feb 19. Circulation. 2014. PMID: 24552833

8

Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling.

He Y, Kozaki K, Karpanen T, Koshikawa K, Yla-Herttuala S, Takahashi T, Alitalo K. He Y, et al. Among authors: karpanen t. J Natl Cancer Inst. 2002 Jun 5;94(11):819-25. doi: 10.1093/jnci/94.11.819. J Natl Cancer Inst. 2002. PMID: 12048269

9

Vascular endothelial growth factor (VEGF)/VEGF-C mosaic molecules reveal specificity determinants and feature novel receptor binding patterns.

Jeltsch M, Karpanen T, Strandin T, Aho K, Lankinen H, Alitalo K. Jeltsch M, et al. Among authors: karpanen t. J Biol Chem. 2006 Apr 28;281(17):12187-95. doi: 10.1074/jbc.M511593200. Epub 2006 Feb 27. J Biol Chem. 2006. PMID: 16505489 Free article.

10

Functional interaction of VEGF-C and VEGF-D with neuropilin receptors.

Kärpänen T, Heckman CA, Keskitalo S, Jeltsch M, Ollila H, Neufeld G, Tamagnone L, Alitalo K. Kärpänen T, et al. FASEB J. 2006 Jul;20(9):1462-72. doi: 10.1096/fj.05-5646com. FASEB J. 2006. PMID: 16816121

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

66 results

Search Page